From components to pharmaceuticals: A desirable evolution toward precision transfusion medicine
Transfusion · 2026-11 · 66 (11) · 2450-2455
DOI: 10.1111/trf.70402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, online erschienen am 26.09.2026. Verfasst von Melissa M Cushing und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA. Die Arbeit nennt 55 Literaturangaben.
Abstract (Originalsprache)
Modern medicine demands pharmaceutical therapies that are dose-defined, predictable, and reproducible.1 The United States Food & Drug Administration (FDA) evaluates drugs based on purity, potency, stability, sterility, and consistency.2,3 Yet transfusion medicine continues to rely primarily on "units" of biologic products (e.g., red blood cells (RBCs), platelets, plasma), the composition of which, and the resulting clinical effects, vary substantially from unit to unit.Consider insulin.For decades, patients received crude pancreatic extracts of inconsistent potency.4 However, the advent of purified, and then recombinant, insulin, with defined purity and dose, and with predictable pharmacokinetics, revolutionized diabetes care and became the widely accepted standard.4 As a result, no endocrinologist would return to the use of variable animal extracts because they "worked well enough."Nonetheless, most of transfusion medicine remains in its pre-pharmaceutical era, administering blood components whose therapeutic effects cannot be precisely predicted from the dose given,
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.
- Department of Pathology and Cell Biology, Columbia University, New York, New York, USA.
ORCID-Profile: Melissa M Cushing, Steven L Spitalnik
Zitieren
APA
Cushing, M. M., & Spitalnik, S. L. (2026). From components to pharmaceuticals: A desirable evolution toward precision transfusion medicine. Transfusion, 66(11), 2450-2455. https://doi.org/10.1111/trf.70402
Vancouver
Cushing MM, Spitalnik SL. From components to pharmaceuticals: A desirable evolution toward precision transfusion medicine. Transfusion. 2026;66(11):2450-2455. doi:10.1111/trf.70402
BibTeX
@article{Cushing2026,
author = {Cushing, Melissa M and Spitalnik, Steven L},
title = {From components to pharmaceuticals: A desirable evolution toward precision transfusion medicine},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {11},
pages = {2450--2455},
doi = {10.1111/trf.70402}
}
EUVIMED